What AN2 Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 1 |
| Sells | 9 | 22 |
| Total trades | 15 | 42 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 123,902 | 452,446 |
| Disposed | 458,781 | 518,276 |
| Net activity | −334,879 | −65,830 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Martin Patricia A. | Director | Oct 12 | Grant / award · A | +389 | — | — | 19,252 |
| Aziz Kabeer | Director | Oct 12 | Grant / award · A | +2,465 | — | — | 61,571 |
| Marks Gilbert Lynn | Director | Oct 12 | Grant / award · A | +2,283 | — | — | 84,156 |
| Trenor Cameron C. Iii | Chief Medical Officer | Sep 15 | Grant / award · A | +116,667 | — | — | 116,667 |
| Readnour Robin Shane | Director | Sep 09 | Open-market sale · S | −585 | $6.02 | −$3.52K | 624,765 |
| Readnour Robin Shane | Director | Sep 09 | Open-market sale · S | −523 | $6.02 | −$3.15K | 557,467 |
| Readnour Robin Shane | Director | Sep 08 | Open-market sale · S | −5,294 | $6.02 | −$31.9K | 625,350 |
| Readnour Robin Shane | Director | Sep 08 | Open-market sale · S | −4,725 | $6.02 | −$28.4K | 557,990 |
| Readnour Robin Shane | Director | Sep 03 | Open-market sale · S | −3,223 | $6.07 | −$19.6K | 630,644 |
| Readnour Robin Shane | Director | Sep 03 | Open-market sale · S | −2,877 | $6.07 | −$17.5K | 562,715 |
| Williams Sarah Joanne | Principal Accounting Officer | Sep 01 | Sale for tax withholding · S | −272 | $5.53 | −$1.5K | 66,311 |
| FitzPatrick Margaret M | Director | Sep 01 | Open-market buy · P | +2,098 | $5.53 | +$11.6K | 10,708 |
| Readnour Robin Shane | Director | Aug 17 | Open-market sale · S | −18,706 | $6.01 | −$112K | 633,867 |
| Readnour Robin Shane | Director | Aug 17 | Open-market sale · S | −16,696 | $6.01 | −$100K | 565,592 |
| Zakrzewski Joseph S | Director | Aug 14 | Gift · G | −405,880 | — | — | 0 |
| Martin Patricia A. | Director | Jul 10 | Grant / award · A | +766 | — | — | 18,863 |
| Marks Gilbert Lynn | Director | Jul 10 | Grant / award · A | +2,789 | — | — | 81,873 |
| Aziz Kabeer | Director | Jul 10 | Grant / award · A | +2,852 | — | — | 59,106 |
| Eizen Joshua M | See Remarks | Jul 08 | Sale for tax withholding · S | −5,945 | $4.17 | −$24.8K | 206,554 |
| Williams Sarah Joanne | Principal Accounting Officer | May 29 | Sale for tax withholding · S | −265 | $4.43 | −$1.17K | 66,583 |
Loading...
